30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Checkmate Pharmaceuticals Inc (CMPI)

Track

Stock chart
Ticker: CMPI Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
venBio Global Strategic Fund II L.P.
1 sale — total 1,001,100 USD
Sale 16 May 2022
Value US$3,267,956.94 | Price 142.04 | Shares 23,791
Sale 13 May 2022
Value US$451,920.89 | Price 223.65 | Shares 23,388
Sale 12 May 2022
Value US$1,294,312.85 | Price 10.39 | Shares 124,525
Sale 11 May 2022
Value US$183,641.04 | Price 10.38 | Shares 17,700
Sale 10 May 2022
Value US$193,869.95 | Price 10.38 | Shares 18,676
Sale 9 May 2022
Value US$182,582.40 | Price 10.37 | Shares 17,600
Sale 6 May 2022
Value US$501,233.25 | Price 10.37 | Shares 48,334
Sale 5 May 2022
Value US$215,104.91 | Price 10.37 | Shares 20,743
Sale 4 May 2022
Value US$388,923.75 | Price 10.37 | Shares 37,500
Sale 3 May 2022
Value US$824,433.91 | Price 10.37 | Shares 79,475
Sale 2 May 2022
Value US$1,595,974.69 | Price 10.38 | Shares 153,700
Sale 29 Apr 2022
Value US$718,662.78 | Price 10.38 | Shares 69,230
Sale 28 Apr 2022
Value US$761,936.04 | Price 10.38 | Shares 73,400
Sale 27 Apr 2022
Value US$491,979.96 | Price 10.38 | Shares 47,396
Sale 26 Apr 2022
Value US$671,558.31 | Price 10.38 | Shares 64,683
Sale 25 Apr 2022
Value US$287,404.12 | Price 10.39 | Shares 27,668
Sale 22 Apr 2022
Value US$388,834.07 | Price 10.39 | Shares 37,430
Sale 21 Apr 2022
Value US$645,866.14 | Price 10.38 | Shares 62,200
Sale 20 Apr 2022
Value US$889,387.00 | Price 10.39 | Shares 85,611
Sale 19 Apr 2022
Value US$4,165,238.04 | Price 10.42 | Shares 399,923
Sale 25 Feb 2022
Value US$810.96 | Price 2.70 | Shares 300
Sale 24 Feb 2022
Value US$16,978.66 | Price 2.83 | Shares 5,990
Sale 23 Feb 2022
Value US$5,277.45 | Price 2.90 | Shares 1,820
Buy 18 Jun 2021
Value US$43,632.96 | Price 6.04 | Shares 7,224
Buy 16 Jun 2021
Value US$22,112.04 | Price 6.18 | Shares 3,578
Buy 18 May 2021
Value US$174,256.97 | Price 6.97 | Shares 25,001
Planned buy 26 Mar 2021
Value US$42,330.60 | Price 12.15 | Shares 3,484
Planned buy 25 Mar 2021
Value US$123,944.60 | Price 12.35 | Shares 10,036
Buy 27 Jan 2021
Value US$22,198.05 | Price 13.05 | Shares 1,701
Buy 19 Jan 2021
Value US$6,545.00 | Price 13.09 | Shares 500
Buy 22 Dec 2020
Value US$74,707.92 | Price 14.64 | Shares 5,103
Buy 16 Dec 2020
Value US$70,249.10 | Price 14.62 | Shares 4,805
Buy 15 Dec 2020
Value US$608.58 | Price 14.49 | Shares 42
Buy 11 Aug 2020
Value US$7,500,000.00 | Price 15.00 | Shares 500,000
Buy 11 Aug 2020
Value US$1,999,995.00 | Price 15.00 | Shares 133,333
Buy 11 Aug 2020
Value US$3,000,000.00 | Price 15.00 | Shares 200,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-17 2022-05-16 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
23,791 -1.1%
142.04
US$3,267,957 		23,791 -1.1% 142.04 US$3,267,957
2022-05-17 2022-05-13 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
23,388 +37.4%
223.65
US$451,921 		23,388 +37.4% 223.65 US$451,921
2022-05-12 2022-05-12 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
58,202 +19.5%
461.89
US$3,562,330 		58,202 +19.5% 461.89 US$3,562,330
2022-05-12 2022-05-11 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
17,700 -0.7%
10.38
US$183,641 		17,700 -0.7% 10.38 US$183,641
2022-05-12 2022-05-10 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
18,676 -0.8%
10.38
US$193,870 		18,676 -0.8% 10.38 US$193,870
2022-05-09 2022-05-09 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
17,600 -0.7%
10.37
US$182,582 		17,600 -0.7% 10.37 US$182,582
2022-05-09 2022-05-06 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
48,334 -1.9%
10.37
US$501,233 		48,334 -1.9% 10.37 US$501,233
2022-05-09 2022-05-05 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
20,743 -0.8%
10.37
US$215,105 		20,743 -0.8% 10.37 US$215,105
2022-05-04 2022-05-04 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
37,500 -1.5%
10.37
US$388,924 		37,500 -1.5% 10.37 US$388,924
2022-05-04 2022-05-03 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
79,475 -3.0%
10.37
US$824,434 		79,475 -3.0% 10.37 US$824,434
2022-05-04 2022-05-02 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
153,700 -5.5%
10.38
US$1,595,975 		153,700 -5.5% 10.38 US$1,595,975
2022-04-29 2022-04-29 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
69,230 -2.4%
10.38
US$718,663 		69,230 -2.4% 10.38 US$718,663
2022-04-29 2022-04-28 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
73,400 -2.5%
10.38
US$761,936 		73,400 -2.5% 10.38 US$761,936
2022-04-29 2022-04-27 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
47,396 -1.6%
10.38
US$491,980 		47,396 -1.6% 10.38 US$491,980
2022-04-26 2022-04-26 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
64,683 -2.1%
10.38
US$671,558 		64,683 -2.1% 10.38 US$671,558
2022-04-26 2022-04-25 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
27,668 -0.9%
10.39
US$287,404 		27,668 -0.9% 10.39 US$287,404
2022-04-26 2022-04-22 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
37,430 -1.2%
10.39
US$388,834 		37,430 -1.2% 10.39 US$388,834
2022-04-21 2022-04-21 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
62,200 -2.0%
10.38
US$645,866 		62,200 -2.0% 10.38 US$645,866
2022-04-21 2022-04-20 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
85,611 -2.6%
10.39
US$889,387 		85,611 -2.6% 10.39 US$889,387
2022-04-21 2022-04-19 S Sale
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
399,923 -10.9%
10.42
US$4,165,238 		399,923 -10.9% 10.42 US$4,165,238
2022-02-25 2022-02-25 S Sale
2.3
Novo Holdings A/S
Large shareholder
300 -0.0%
2.70
US$811 		300 -0.0% 2.70 US$811
2022-02-25 2022-02-24 S Sale
2.3
Novo Holdings A/S
Large shareholder
5,990 -0.3%
2.83
US$16,979 		5,990 -0.3% 2.83 US$16,979
2022-02-25 2022-02-23 S Sale
2.3
Novo Holdings A/S
Large shareholder
1,820 -0.1%
2.90
US$5,277 		1,820 -0.1% 2.90 US$5,277
2021-06-21 2021-06-18 B Purchase
Krieg Arthur M

Chief Scientific Officer

Officer
7,224 +0.9%
6.04
US$43,633 		7,224 +0.9% 6.04 US$43,633
2021-06-17 2021-06-16 B Purchase
Krieg Arthur M

Chief Scientific Officer

Officer
3,578 +0.4%
6.18
US$22,112 		3,578 +0.4% 6.18 US$22,112
2021-05-19 2021-05-18 B Purchase
Krieg Arthur M

Chief Scientific Officer

Officer
25,001 +3.2%
6.97
US$174,257 		25,001 +3.2% 6.97 US$174,257
2021-03-29 2021-03-26 PP Planned purchase
Krieg Arthur M

Chief Scientific Officer

Officer
3,484 +0.5%
12.15
US$42,331 		3,484 +0.5% 12.15 US$42,331
2021-03-29 2021-03-25 PP Planned purchase
Krieg Arthur M

Chief Scientific Officer

Officer
10,036 +1.4%
12.35
US$123,945 		10,036 +1.4% 12.35 US$123,945
2021-01-28 2021-01-27 B Purchase
Krieg Arthur M

Chief Scientific Officer

Officer
1,701 +0.2%
13.05
US$22,198 		1,701 +0.2% 13.05 US$22,198
2021-01-21 2021-01-19 B Purchase
Krieg Arthur M

Chief Scientific Officer

Officer
500 +0.1%
13.09
US$6,545 		500 +0.1% 13.09 US$6,545
2020-12-23 2020-12-22 B Purchase
Krieg Arthur M

Chief Scientific Officer

Officer
5,103 +0.7%
14.64
US$74,708 		5,103 +0.7% 14.64 US$74,708
2020-12-17 2020-12-16 B Purchase
Krieg Arthur M

Chief Scientific Officer

Officer
4,805 +0.7%
14.62
US$70,249 		4,805 +0.7% 14.62 US$70,249
2020-12-17 2020-12-15 B Purchase
Krieg Arthur M

Chief Scientific Officer

Officer
42 +0.0%
14.49
US$609 		42 +0.0% 14.49 US$609
2020-08-13 2020-08-11 B Purchase
2.3
Novo Holdings A/S
Large shareholder
500,000 +29.9%
15.00
US$7,500,000 		500,000 +29.9% 15.00 US$7,500,000
2020-08-12 2020-08-11 B Purchase
3.6
POWELL MICHAEL
Non-Executive Director Large shareholder
133,333 +3.8%
15.00
US$1,999,995 		133,333 +3.8% 15.00 US$1,999,995
2020-08-12 2020-08-11 B Purchase
2.5
venBio Global Strategic Fund II L.P.
Large shareholder
200,000 +5.8%
15.00
US$3,000,000 		200,000 +5.8% 15.00 US$3,000,000
Explore more

More insider trading research around Checkmate Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America